Wang Q, Li L, Xu E, Wong V, Rhodes C, Brubaker PL (2004) Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells
A study in JAMA Ophthalmology suggested that people taking semaglutide, especially those with type 2 diabetes , may face a significantly higher risk of developing NAION compared to those on other medications
Explore the science, dosing, and safety, all reviewed against the literature
Alternative GLP-1 receptor agonists or different classes of diabetes medications may be considered if Ozempic is poorly tolerated in the context of diverticular disease
Pava is also collaborating with David Kupferschmidt, Ph.D